First Clinical Trial With Cannabis for Huntington’s Disease Shows Promising Results

Researchers from the Ramon y Cajal University Hospital’s Foundation for Biomedical Investigation in Madrid have recently completed the first ever clinical trial to investigate a cannabis extract as a treatment for Huntington’s Disease.

Huntington’s Disease is a debilitating neurodegenerative disorder caused by an inherited genetic mutation. Although the disease progresses slowly, patients have difficulty moving, suffer from involuntary tremors, reduced cognitive functioning and psychiatric disorders. Huntington’s Disease has no known cure and little effective drug treatments.

The genetic mutation causes damage to striatal and cortical neurons, putting neuroprotective drugs  at the forefront of Huntington’s Disease research. Initial research has shown that cannabidiol (CBD), a non-psychoactive component of the cannabis oil, displays neuroprotective effects in mice with similar conditions to the disease, but scientists do no know how exactly it works.

Experimental evidence showed researchers that CBD aid neurons with its antioxidant properties. Though CBD and

... read more at: http://www.hightimes.com/read/first-clinical-trial-cannabis-huntington%E2%80%99s-disease-shows-promising-results?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+HIGHTIMESMagazine+(HIGH+TIMES+Magazine)